13h
Stockhead on MSNBiocurious: Cashed up and pursuing the ‘c’ word, Imugene is on the verge of transforming cancer immunotherapyImugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.
Upcoming dividends for Imugene Limited (IMU) are announced to the ASX several weeks before the ex-dividend date. To be a paid a dividend, you must own shares in Imugene Limited (IMU) before the ...
The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the ...
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Imugene Ltd (ASX:IMU) (OTCMKTS:IUGNF) is a clinical-stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to ...
The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the RBA’s rate decision due next week. IT and Staples have been the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results